Listen on the go
CORRECT!
Next question
touchINFECTIOUS DISEASES touchINFECTIOUS DISEASES

Trending Activities
HIV, Sexually Transmitted Infections, Viral Infections
touchPANEL DISCUSSION
Shaping ART around individual needs: Maximizing adherence and quality of life
Prof. Jens Lundgren, Prof. Marta Boffito, Ms Angelina Namiba Translations available:
Watch Time: 38 mins

Watch three experts discuss how to optimize antiretroviral therapy for people living with HIV through an individualized approach to care

Learning objectives
Learning Objectives
  • Assess the individual needs of newly diagnosed people living with HIV who are initiating ART
  • Apply shared decision making to select the most appropriate first-line ART regimen for people living with HIV
  • Use relevant monitoring strategies for people living with HIV receiving ART, to revise treatment regimen in line with changes in life and preferences
HIV
touchMDT
From PrEP to long-term ART in HIV: Overcoming barriers to adherence throughout the journey
Dr Laura Waters, Ms Fiona Marra, Ms Catarina Esteves, Ms Susan Cole
Watch Time: 50 mins

Key stakeholders discuss considerations for supporting adherence to PrEP and ART in people at risk of, or living with, HIV.

Learning objectives
Learning Objectives
  • Outline the factors leading to poor adherence to PrEP and how they can be overcome in clinical practice
  • Describe the challenges of ART initiation and adherence in newly diagnosed PLHIV and how to optimize monitoring and care of PLHIV
  • Discuss how care centred on the needs of PLHIV and new therapeutic approaches may improve overall quality of life and adherence to long-term ART in ageing adults living with HIV

Curriculum Activities

Learn more with a series of activities which are linked and developed as a curriculum

COVID-19
touchCURRICULUM
Prevention, diagnosis and early-stage management of COVID-19 – A crisis in the developing world

Watch a series of expert interviews on patient management during the COVID-19 pandemic, discussing issues such as mucormycosis, transmission and appropriate steriod treatment , all pertinent to the developing world.

Including:

touchEXPERT OPINIONS

Managing patients with COVID-19 in respiratory distress: What is the role of steroids?

touchEXPERT OPINIONS

COVID-19: How can transmission be prevented and controlled?

touchEXPERT OPINIONS

Mucormycosis: What is it and how can it be avoided in patients with COVID-19

touchEXPERT OPINIONS

COVID-19 in clinical practice

COVID-19
Curriculum Inclusions:
  • Describe the benefits of steroid use in patients with COVID-19 and appropriate use
  • Summarize viral load and transmission rates and their relevance in controlling a pandemic
  • Discuss how the risk of COVID-19-related mucormycosis can be minimized in predisposed patients
  • Review the approach to patient management in both the home and clinical settings during the COVID-19 pandemic

All Activities

View all Education activities

HIV, Sexually Transmitted Infections, Viral Infections
Watch Time: 38 mins
touchPANEL DISCUSSION
Shaping ART around individual needs: Maximizing adherence and quality of life
Prof. Jens Lundgren, Prof. Marta Boffito, Ms Angelina Namiba Translations available:

Watch three experts discuss how to optimize antiretroviral therapy for people living with HIV through an individualized approach to care

Learning objectives
Learning Objectives
  • Assess the individual needs of newly diagnosed people living with HIV who are initiating ART
  • Apply shared decision making to select the most appropriate first-line ART regimen for people living with HIV
  • Use relevant monitoring strategies for people living with HIV receiving ART, to revise treatment regimen in line with changes in life and preferences
HIV
Watch Time: 50 mins
touchMDT
From PrEP to long-term ART in HIV: Overcoming barriers to adherence throughout the journey
Dr Laura Waters, Ms Fiona Marra, Ms Catarina Esteves, Ms Susan Cole

Key stakeholders discuss considerations for supporting adherence to PrEP and ART in people at risk of, or living with, HIV.

Learning objectives
Learning Objectives
  • Outline the factors leading to poor adherence to PrEP and how they can be overcome in clinical practice
  • Describe the challenges of ART initiation and adherence in newly diagnosed PLHIV and how to optimize monitoring and care of PLHIV
  • Discuss how care centred on the needs of PLHIV and new therapeutic approaches may improve overall quality of life and adherence to long-term ART in ageing adults living with HIV
COVID-19
Watch Time: 10 mins
touchEXPERT OPINIONS
COVID-19 in clinical practice
Dr Mangesh Tiwaskar, Dr Sonali Kinra Translations available:

Dr Tiwaskar and Dr Kinra share their experiences of managing patients at the onset of the COVID-19 pandemic and the key lessons learnt in clinical practice within India and the UK.

COVID-19, Fungal Infections
Watch Time: 6 mins
touchEXPERT OPINIONS
Mucormycosis: What is it and how can it be avoided in patients with COVID-19
Prof. Partha Kar, Dr Syed Shoeb Ahmad, Dr Neil Stone Translations available:

Prof. Partha Kar, Dr Syed Shoeb Ahmad and Dr Neil Stone share their insights into the risk factors for mucormycosis in patients with COVID-19 and how it can be avoided.

COVID-19
Watch Time: 9 mins
touchEXPERT OPINIONS
COVID-19: How can transmission be prevented and controlled?
Dr Sanjay Kalra Translations available:

Join Dr Sanjay Kalra as he discusses viral transmission in COVID-19 and strategies to prevent transmission.

COVID-19
Watch Time: 11 mins
touchEXPERT OPINIONS
Managing patients with COVID-19 in respiratory distress: What is the role of steroids?
Dr Viny Kantroo Translations available:

Dr Viny Kantroo shares her experiences of steroid treatment in patients with COVID-19 and respiratory distress.

IME
Education activities are developed by touchIME for touchINFECTIOUS DISEASES.

Our education resources are developed in collaboration with our well established peer-reviewed medical journals, our Editorial Board members and partnerships with major medical societies, with a clear commitment to high-quality independent education.

Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72